45results about How to "Extensive interaction" patented technology

An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogeneous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose / response profiles within a short time span.

The present invention is directed to a method for determining the effect of each of a plurality of test agents on cells from a subject, and a method to profile patient cell responses to test agents.

A coating for use in combustion systems includes a plurality of refractory metal particles in a ceramic, glass or metal matrix disposed on surfaces of the system that are prone to slag, ash, and / or char buildup during operation of the combustion system. The coating is effective to prevent any substantial interaction with the slag, ash, and / or char.

The present application discloses an apparatus for gasification of solid, liquid and gaseous organic feed materials having a fuel value into synthesis gas. The apparatus comprises: a gasification reactor vessel having a tapered interior with a minimum of four zones for introducing reaction gas mixtures, a central perforated diffuser pipe, a solid and liquid material inlet at the upper end of the uppermost zone, a solid and gas discharge outlet at the lower end of the bottom zone, wherein the reactor vessel defining a sequence of reaction zones from the material inlet to the material outlet including drying, pyrolysis, combustion and gasification zones, and confining downwardly moving the column of the feed materials within the zones, gas feed inlet pipes for introducing reaction gas into the zones, a synthesis gas discharge pipe below the zones, and a heat exchanger below the zones.

The present invention relates to a class of fluorescent, organic nanofibrils, and particularly the films comprising entangled piling of these nanofibrils exhibiting effective quenching of their fluorescence upon exposure the vapor of explosives. The invention also relates to a sensor and a method for sensing the explosives vapor and other volatile organic compounds, including the explosives taggants through the modulation of the fluorescence of the nanofibril film and the electrical conductivity of the nanofibrils. The invention also relates to a development of synthetic methods, protocols and techniques that leads to production of various arylene-ethynylene macrocycle (AEM) molecules, which consist of a shape-persistent, toroidal scaffold in planar conformation, with minimal ring strain and highly tunable ring sizes (from 0.5 nm to above 10 nm). The invention also relates to an approach to optimization of the one-dimensional molecular arrangement along the long axis of the nanofibril, which provides increased exciton (excited state) migration (via cofacial intermolecular electronic coupling) and charge transport (via pi-electronic delocalization). A combination of long-range exciton migration and efficient charge transport makes the nanofibrils ideal as sensory materials for detecting explosives and other volatile organic compounds through both optical and electrical sensing mechanisms.

The present invention relates to a compound having the general formula (V), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof,which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.

Methods and compositions for treating or preventing microbial infection in mammals with sulfated polysaccharides wherein the polysaccharides have a degree of sulfation effective to enable maximal interaction of constituent sulfate groups with the microbe which causes the infection and wherein the sulfated polysaccharide is not substantially endocytosed or degraded by cell receptor binding in the mammal and thereby retains antimicrobial activity in vivo.

This invention provides a pharmaceutical composition comprising a eutectic composition of two pharmacologically active ingredients for delivery to the lung by inhalation. This invention also provides a pharmaceutical composition comprising a eutectic composition of two pharmacologically active ingredients for the treatment of respiratory disease.

A motor coach comprises a front door, a front stairwell, an upper aisleway, upper seats, a side door and a mobility impaired area. The front stairwell leads from the front door. The upper aisleway leads from the front stairwell. The upper aisleway is generally at the level of the top of the upper stairwell. The upper seats are along the upper aisleway. The side door may be lower than or at the same height as the front door, and leads to the mobility impaired area, which is inside and generally at the level of the bottom of the side door. The upper aisleway, upper seats, and mobility impaired area are all together in one unified passenger compartment while separated by differences of location of doors for loading and heights of floors. Numerous advantages flow, including but not limited to the following: loading and unloading times for mobility impaired passengers are substantially improved, especially as compared to typical high floor, wheelchair lift equipped coaches.

Methods and compositions for treating or preventing microbial infection in mammals with sulfated polysaccharides wherein the polysaccharides have a degree of sulfation effective to enable maximal interaction of constituent sulfate groups with the microbe which causes the infection and wherein the sulfated polysaccharide is not substantially endocytosed or degraded by cell receptor binding in the mammal and thereby retains antimicrobial activity in vivo.